Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Nrx Pharmaceuticals Inc (NRXP)

Nrx Pharmaceuticals Inc (NRXP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 392,851
  • Shares Outstanding, K 58,810
  • Annual Sales, $ 0 K
  • Annual Income, $ -430 K
  • 60-Month Beta 0.28
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 48.57
Trade NRXP with:

Options Overview Details

View History
  • Implied Volatility 184.46%
  • Historical Volatility 213.07%
  • IV Percentile 81%
  • IV Rank 57.67%
  • IV High 230.86% on 08/12/21
  • IV Low 121.23% on 11/18/21
  • Put/Call Vol Ratio 0.43
  • Today's Volume 5,872
  • Volume Avg (30-Day) 3,775
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 11,848
  • Open Int (30-Day) 13,180

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.07 +67.08%
on 11/23/21
10.39 -34.55%
on 11/29/21
-3.11 (-31.38%)
since 11/01/21
3-Month
4.07 +67.08%
on 11/23/21
16.99 -59.98%
on 09/02/21
-9.20 (-57.50%)
since 09/01/21
52-Week
4.07 +67.08%
on 11/23/21
76.99 -91.17%
on 12/22/20
-4.10 (-37.61%)
since 12/01/20

Most Recent Stories

More News
Company News for Nov 30, 2021

Companies in the news are: KRYS, ADGI, NRXP, HTZ

HTZ : 24.58 (+1.74%)
KRYS : 75.25 (-6.58%)
NRXP : 6.80 (+1.80%)
ADGI : 44.00 (-6.46%)
NRx Pharmaceuticals Identifies Significantly Higher Likelihood of Surviving and Recovering from Critical COVID-19 in ZYESAMI® (aviptadil) Treated Patients Previously Administered Remdesivir

Analysis was conducted in the subgroup of ZYESAMI- and placebo-treated patients who were previously treated with remdesivir in the COVID-AIV trial...

NRXP : 6.80 (+1.80%)
NRx Pharmaceuticals Notes New Data on BriLife® COVID-19 Vaccine Effectiveness Against Delta Variant Posted by Israel Institute for Biological Research

Analysis of Blood Samples from Patients who Responded to the BriLife® Vaccine During Phase 2 Trial Suggests that the Same Level of Response was Seen...

NRXP : 6.80 (+1.80%)
Relief Reports that its U.S. Collaboration Partner has Announced the U.S. Food and Drug Administration has Denied Breakthrough Designation for Aviptadil

GENEVA, SWITZERLAND / ACCESSWIRE / November 24, 2021 / RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (" Relief "), a biopharmaceutical company seeking to provide patients therapeutic relief...

RLFTF : 0.0678 (-8.25%)
RLFTY : 10.7800 (-2.55%)
NRXP : 6.80 (+1.80%)
NRx Pharmaceuticals Reports Third-Quarter 2021 Business Update and Financial Results

RADNOR, Pa., Nov. 16, 2021 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals (Nasdaq: NRXP) (NRx), a clinical-stage, biopharmaceutical company, today provided a...

NRXP : 6.80 (+1.80%)
NRx Pharmaceutical’s Chairman and Chief Executive Officer Jonathan Javitt to Present Company Business Update at H.C. Wainwright 7th Annual Israel Conference

Conference Begins on November 15, 2021...

NRXP : 6.80 (+1.80%)
Relief Reports that its U.S. Collaboration Partner has Announced it has Received a U.S. Food and Drug Administration Review of Aviptadil Manufacturing Information

GENEVA, SWITZERLAND / ACCESSWIRE / November 12, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF) (" Relief "), a biopharmaceutical company seeking to provide patients therapeutic relief from...

RLFTF : 0.0678 (-8.25%)
NRXP : 6.80 (+1.80%)
NRx Pharmaceuticals Receives US Food and Drug Administration Review of ZYESAMI® (aviptadil) Manufacturing Information

US Food and Drug Administration Review Allows for High Volume Production of ZYESAMI® (aviptadil)Shelf Life of ZYESAMI Now Extended from 62 Days to 150 Days...

NRXP : 6.80 (+1.80%)
NRx Pharmaceuticals to Report Third Quarter 2021 Financial and Business Update on Tuesday, November 16, 2021

--Company to Host Conference Call on Tuesday, November 16, 2021, at 8:30AM ET--...

NRXP : 6.80 (+1.80%)
Relief Reports U.S. Collaboration Partner's Emergency Use Authorization Request for ZYESAMI/RLF-100 (aviptadil) for Patients with Critical COVID-19 with Respiratory Failure was Declined by U.S. FDA

GENEVA, SWITZERLAND / ACCESSWIRE / November 5, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF) ("Relief"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious...

RLFTF : 0.0678 (-8.25%)
NRXP : 6.80 (+1.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

NRX Pharmaceuticals Inc. is a patient-focused, clinical stage pharmaceutical company. It creates therapies to treat diseases where no medicines currently exist. NRX Pharmaceuticals Inc., formerly known as Big Rock Partners Acquisition Corp., is based in RADNOR, Pa.

See More

Key Turning Points

3rd Resistance Point 9.24
2nd Resistance Point 8.62
1st Resistance Point 7.65
Last Price 6.80
1st Support Level 6.06
2nd Support Level 5.44
3rd Support Level 4.47

See More

52-Week High 76.99
Fibonacci 61.8% 49.13
Fibonacci 50% 40.53
Fibonacci 38.2% 31.93
Last Price 6.80
52-Week Low 4.07

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar